Misbah Aziz is a Ph.D. student in the third year of her degree at the Department of Diabetes, Monash University. Melbourne. Her research interest is about the epigenetics basis of diabetic-associated cardiovascular disease.

Thomas King is a final year PhD candidate at the University of New South Wales Sydney - School of Biomedical Sciences investigating the use of apolipoprotein mimetic peptides as a potential disease modifying therapy for Type 1 Diabetes.

Dr Tomasz Block is an Endocrinology Research Fellow at Alfred Hospital in Melbourne. Alongside clinical practice, he is undertaking a NHMRC funded PhD supervised by Professors Merlin Thomas and Mark Cooper within the Department of Diabetes at Monash University, investigating the role of RNA therapy to treat diabetic cardiovascular and renal complications.

Nicholas is a final year PhD candidate in the Faculty of Medicine and Health and the University of Sydney. His research employs mass spectrometry and confocal imaging to investigate the insulin secretory granule.

Amanda Purcell is a PhD candidate at the University of Sydney investigating the use of incretin based therapies for individuals with type 1 diabetes and overweight/obesity.

Braden's research encompasses fundamental laboratory science and small animal experiments, clinical studies in people with type 2 diabetes, and bioinformatic and biostatistical analyses of large datasets from cohort studies. His work aims to investigate the mechanisms linking non-nutritive sweeteners to impaired glycaemic control in health and type 2 diabetes

Dr Mai Thao Tran commenced PhD in Prof. Jamie Rossjohn's laboratory (2018). After completing PhD in 2022, she continued to work on the project examining the role of a novel post-translational modification, peptide fusion, in the generation and recognition of neo-antigens involved in the pathogenesis of type 1 diabetes.

Melkam Kebede is a cell biologist with a strong interest in understanding the cause of reduced glucose stimulated insulin secretion in type 2 diabetes. She heads the Islet Biology and Metabolism laboratory at the Charles Perkins Centre, University of Sydney. Melkam studies the pancreatic beta-cell with specific interests in understanding the mechanisms behind insulin secretory granule biogenesis, maturation, stability and targeting for secretion. Her laboratory uses a combination of mass spectrometry, flow cytometry, microscopy, cell and molecular biology approaches to help understand these processes in cell and animal models of type 2 diabetes. Her research has been funded by Diabetes Australia Research Program and the NHMRC project and Ideas grants.